a developer of biomedical research products in the field of stem cells and regenerative medicine
Industry Biotechnology
A.I.dvisor tells us that ERNA and VSTM have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERNA and VSTM's prices will move in lockstep.
| Ticker / NAME | Correlation To ERNA | 1D Price Change % | ||
|---|---|---|---|---|
| ERNA | 100% | -6.60% | ||
| VSTM - ERNA | 25% Poorly correlated | -3.20% | ||
| LXRX - ERNA | 25% Poorly correlated | -6.94% | ||
| CGTX - ERNA | 23% Poorly correlated | -10.88% | ||
| ARVN - ERNA | 23% Poorly correlated | -2.52% | ||
| XCUR - ERNA | 23% Poorly correlated | -1.44% | ||
More | ||||
| Ticker / NAME | Correlation To ERNA | 1D Price Change % |
|---|---|---|
| ERNA | 100% | -6.60% |
| regenerative medicine theme (2 stocks) | 62% Loosely correlated | -3.48% |
| stem cells theme (21 stocks) | 14% Poorly correlated | +0.41% |
| medical service theme (156 stocks) | 14% Poorly correlated | +0.31% |
| medical research theme (128 stocks) | 13% Poorly correlated | +0.46% |
| biological theme (25 stocks) | 8% Poorly correlated | +0.34% |